These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24844163)

  • 41. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
    Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
    Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
    Ke Z; Guo H; Zhu X; Jin Y; Huang Y
    J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fabrication of coated bovine serum albumin (BSA)-epigallocatechin gallate (EGCG) nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells.
    Li Z; Ha J; Zou T; Gu L
    Food Funct; 2014 Jun; 5(6):1278-85. PubMed ID: 24741679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dexamethasone-loaded nanoparticle-coated microparticles: correlation between in vitro drug release and drug transport across Caco-2 cell monolayers.
    Beck RC; Pohlmann AR; Hoffmeister C; Gallas MR; Collnot E; Schaefer UF; Guterres SS; Lehr CM
    Eur J Pharm Biopharm; 2007 Aug; 67(1):18-30. PubMed ID: 17317124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Permeation of disaccharides derived from chondroitin sulfate through human intestinal Caco-2 cell monolayers via the paracellular pathway.
    Jin M; Satsu H; Yamada K; Hisada N; Totsuka M; Shimizu M
    Biosci Biotechnol Biochem; 2010; 74(6):1243-9. PubMed ID: 20530904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transmucosal macromolecular drug delivery.
    Prego C; García M; Torres D; Alonso MJ
    J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
    Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
    Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery.
    Liu Y; Yang T; Wei S; Zhou C; Lan Y; Cao A; Yang J; Wang W
    Int J Pharm; 2018 Feb; 537(1-2):245-256. PubMed ID: 29288808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an EGTA-conjugated carrier for oral insulin delivery.
    Chuang EY; Lin KJ; Su FY; Chen HL; Maiti B; Ho YC; Yen TC; Panda N; Sung HW
    J Control Release; 2013 Aug; 169(3):296-305. PubMed ID: 23195534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity.
    Huotari A; Xu W; Mönkäre J; Kovalainen M; Herzig KH; Lehto VP; Järvinen K
    Int J Pharm; 2013 Sep; 454(1):67-73. PubMed ID: 23834832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure.
    Béduneau A; Tempesta C; Fimbel S; Pellequer Y; Jannin V; Demarne F; Lamprecht A
    Eur J Pharm Biopharm; 2014 Jul; 87(2):290-8. PubMed ID: 24704198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium.
    Uskoković V; Lee PP; Walsh LA; Fischer KE; Desai TA
    Biomaterials; 2012 Feb; 33(5):1663-72. PubMed ID: 22116000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of conjugate-by-conjugate structured nanoparticles for oral delivery of docetaxel.
    Ha-Lien Tran P; Wang T; Yang C; Tran TTD; Duan W
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110346. PubMed ID: 31761193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart.
    Tölli MA; Ferreira MP; Kinnunen SM; Rysä J; Mäkilä EM; Szabó Z; Serpi RE; Ohukainen PJ; Välimäki MJ; Correia AM; Salonen JJ; Hirvonen JT; Ruskoaho HJ; Santos HA
    Biomaterials; 2014 Sep; 35(29):8394-405. PubMed ID: 24985734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin.
    Tsai LC; Chen CH; Lin CW; Ho YC; Mi FL
    Int J Biol Macromol; 2019 Apr; 126():141-150. PubMed ID: 30586591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study.
    Vllasaliu D; Casettari L; Fowler R; Exposito-Harris R; Garnett M; Illum L; Stolnik S
    Int J Pharm; 2012 Jul; 430(1-2):151-60. PubMed ID: 22525084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides.
    Rytkönen J; Arukuusk P; Xu W; Kurrikoff K; Langel U; Lehto VP; Närvänen A
    Mol Pharm; 2014 Feb; 11(2):382-90. PubMed ID: 24341621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
    Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
    Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A; Tozuka Y; Takeuchi H
    Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
    Krauland AH; Guggi D; Bernkop-Schnürch A
    Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.